Title:Investigation of Therapeutic Drug Monitoring of Tacrolimus in Different
Age Groups: Results from a Turkish Nationwide Study
Volume: 20
Issue: 6
Author(s): Murat Caglayan*, Ataman Gonel, Osman Celik, Abdulvahit Sozuer, Mustafa Mahir Ulgu, Naim Ata and Suayip Birinci
Affiliation:
- Department of Medical Biochemistry, Diskapi Yildirim Beyazit Training and Research Hospital, Health Science University,
Ankara, Turkey
Keywords:
Tacrolimus, elderly, big data, drug analysis, drug monitoring, optimum immunosuppression.
Abstract:
Background: The blood level of tacrolimus (TAC) used for post-transplant immunosuppression
should be within the therapeutic index. Geriatric individuals may be at risk of organ rejection because,
in this age group, routine drug use is usually disrupted, and the bioavailability of aging-related
drugs is decreased.
Objective: The aim of this study was to analyze the age-related variability of blood TAC levels in patients
in Turkey.
Methods: In this study, 697,616 patients who underwent TAC measurement in the laboratories of public,
private, and university hospitals between 2018 and 2020 were identified from the Health-net database of
the Ministry of Health. The results of patients aged ≥65 years were compared with those of patients aged
<65 years. The differences between the sexes in the same age group were also examined. Data from the
Turkish Ministry of Health National Electronic Database were used to design a multicenter retrospective
cohort study.
Results: The study included 697,616 patients. The mean TAC concentration was 7.2 ± 6.25 ng/mL for all
the patients, 7.13 ± 6.7 ng/mL for the female patients, and 7.24 ± 5.96 ng/mL for the male patients. A
statistically significant difference in TAC concentration was found between men and women in the general
population. Groups aged ≥65 years were compared among themselves. A statistically significant decrease
in TAC concentration was found only in the age group of 75–79 years (5.63 ± 4.09 ng/mL) of
women compared with the men. In all other age groups, the TAC levels of the men were lower.
Conclusion: The proportion of patients with TAC concentrations lower than the therapeutic index was
higher in the groups aged ≥65 years. Thus, patients aged ≥65 years may be at risk of organ rejection, as
optimum immunosuppression cannot be achieved. In these patients, more frequent drug monitoring and
providing training to ensure the compliance of the patient and the patient's relatives in the use of TAC
may be recommended.
